Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cytokines, Cellular & Molecular Therapy|June 13, 2000
Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapyJ Crawford, D K Tomita, R Mazanet, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase IV trial of daily oral etoposide in the treatment of advanced soft-tissue sarcomaJ D Licht, R Mazanet, P J Loehrer, et al.Journal of Hematotherapy|January 1, 1993
The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapyA D Elias, L Ayash, I Tepler, et al.Journal of the National Cancer Institute. Monographs|January 1, 1994
High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by ageK Antman, L Ayash, A Elias, et al.British Journal of Haematology|May 1, 1994
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantationL J Ayash, A Elias, M Hunt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility studyL J Ayash, A Elias, C Wheeler, et al.Breast Cancer Research and Treatment|December 1, 1991
GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: two protocolsA D Elias, R Mazanet, C Wheeler, et al.Blood|June 1, 1992
Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancerA D Elias, L Ayash, K C Anderson, et al.Pageof 2